Literature DB >> 22478702

MRSA: The Private-Sector Response.

Virginia Jackson1, David B Nash.   

Abstract

With Medicare eliminating payment for the treatment of several preventable hospital errors and infections, the market for effective infection-control interventions is poised to grow quickly. Products that merge information technology with biotechnology can improve quality of care, reduce unnecessary suffering, and eliminate waste of resources.

Entities:  

Year:  2008        PMID： 22478702      PMCID： PMC2651705     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN： 1554-169X


  9 in total

1.  Debugging hospitals. Technology helps track hospital-acquired infections, along with the often unreimbursed costs of treating them.

Authors:  John Morrissey
Journal:  Mod Healthc       Date:  2004-04-26

2.  Reducing waste in US health care systems.

Authors:  Roger W Bush
Journal:  JAMA       Date:  2007-02-28       Impact factor: 56.272

3.  Methicillin-resistant S. aureus infections among patients in the emergency department.

Authors:  Gregory J Moran; Anusha Krishnadasan; Rachel J Gorwitz; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; David A Talan
Journal:  N Engl J Med       Date:  2006-08-17       Impact factor: 91.245

4.  Estimating health care-associated infections and deaths in U.S. hospitals, 2002.

Authors:  R Monina Klevens; Jonathan R Edwards; Chesley L Richards; Teresa C Horan; Robert P Gaynes; Daniel A Pollock; Denise M Cardo
Journal:  Public Health Rep       Date:  2007 Mar-Apr       Impact factor: 2.792

5.  Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection.

Authors:  Timothy S Naimi; Kathleen H LeDell; Kathryn Como-Sabetti; Stephanie M Borchardt; David J Boxrud; Jerome Etienne; Susan K Johnson; Francois Vandenesch; Scott Fridkin; Carol O'Boyle; Richard N Danila; Ruth Lynfield
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

6.  Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections.

Authors:  Albert G Crawford; Joseph P Fuhr; Bhaskar Rao
Journal:  Infect Control Hosp Epidemiol       Date:  2004-08       Impact factor: 3.254

7.  National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2006.

Authors:  William R Jarvis; JoAnn Schlosser; Raymond Y Chinn; Samantha Tweeten; Marguerite Jackson
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

8.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Authors:  R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272

9.  Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005.

Authors:  Eili Klein; David L Smith; Ramanan Laxminarayan
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883
  9 in total
  1 in total

1.  Secure surveillance of antimicrobial resistant organism colonization or infection in Ontario long term care homes.

Authors:  Khaled El Emam; Luk Arbuckle; Aleksander Essex; Saeed Samet; Benjamin Eze; Grant Middleton; David Buckeridge; Elizabeth Jonker; Ester Moher; Craig Earle
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.